Dasotraline (INN; SEP-225,289) is an antidepressant drug, which was being developed by Sepracor. It is a so-called triple reuptake inhibitor (TRI).
§ADHD study
Clinical trials are being conducted to determine the efficacy and safety of dasotraline in adults with ADHD.
§References
§Further reading
- Liming Shao Patent
- US application 2007203111, Shao L, Wang F, Malcolm SC, Hewitt MC, Bush LR, Ma J, Varney MA, Campbell U, Engel SR, Hardy LW, Koch P, Campbell JE, "Cycloalkylamines as monoamine reuptake inhibitors", published 2007-08-30, assigned to Sepracor Inc.Â
- Asymmetry Patent
- US patent 7129378, Han X, Krishnamurthy D, Senanayake CH, Lu Z-H, "Method of preparing amine stereoisomers", published 2005-07-28, assigned to Apsinterm LLCÂ